Stevanato Group S.p.A. (STVN) Form 6-K — Aug 6, 2026
Stevanato Group reported largely in-line Q2 2026 results with revenue of €302 million, up 8% year-over-year, while adjusted EBITDA rose 21% to €78.7 million and the adjusted EBITDA margin expanded 280 basis points to 26%. Growth was driven by the Biopharmaceutical and Diagnostic Solutions segment (+9%), with high-value solutions revenue up 16% to €135.9 million, or 45% of total revenue. The company completed the divestiture of its California-based Balda C. Brewer subsidiary, recording €12.2 million in one-time expenses that, along with a higher tax rate, held GAAP net profit to €23 million (€0.08 diluted EPS) versus adjusted net profit of €37.6 million (+20%, €0.14 adjusted EPS).
Key figures
- Eps
- €0.08 diluted; €0.14 adjusted diluted
- Revenue
- €302 million (Q2 2026)
- Guidance
- FY2026 revenue €1.260-1.280 billion; adjusted EBITDA €335-345.2 million; adjusted diluted EPS €0.60-0.62; tax rate ~28.2%; free cash flow breakeven to positive €20 million
- Net Income
- €23 million GAAP; €37.6 million adjusted (+20%)
- Revenue Yoy
- 8%
- Cash Position
- €78.6 million
- Capex Q2
- €52 million
- Net Debt
- €360.3 million
- Gross Margin
- 28.7% (+60 bps)
- Adjusted EBITDA
- €78.7 million (+21%)
- Free Cash Flow Q2
- negative €32 million
- Glp1 Revenue Share
- 22-23% of revenue
- Bds Segment Revenue
- €266.2 million (+9%)
- Operating Cash Flow Q2
- €31.9 million
- Adjusted EBITDAMargin
- 26% (+280 bps)
- Adjusted Operating Margin
- 18% (+250 bps)
- Engineering Segment Revenue
- €35.8 million (-2%)
- High Value Solutions Revenue
- €135.9 million (+16%, 45% of total revenue)
- Balda Expected FY2026 Revenue
- €30 million
- Cumulative Investment Since IPO
- €1.3 billion
- Currency Headwind Favorability
- €8 million favorable vs. prior model
- Balda Divestiture One Time Expenses
- €12.2 million
- Guidance Revenue Reduction From Divestiture
- €15 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.